UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053410
Receipt number R000060953
Scientific Title A Prospective Observational Study Aimed at Comprehensive Assessment of Psychiatric Inpatients Based on Objective Data and Prescriptions for Reducing Long-Term Hospitalization
Date of disclosure of the study information 2024/01/22
Last modified on 2024/01/22 12:14:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Prospective Observational Study Aimed at Comprehensive Assessment of Psychiatric Inpatients Based on Objective Data and Prescriptions for Reducing Long-Term Hospitalization

Acronym

A Prospective Observational Study Aimed at Comprehensive Assessment of Psychiatric Inpatients Based on Objective Data and Prescriptions for Reducing Long-Term Hospitalization

Scientific Title

A Prospective Observational Study Aimed at Comprehensive Assessment of Psychiatric Inpatients Based on Objective Data and Prescriptions for Reducing Long-Term Hospitalization

Scientific Title:Acronym

A Prospective Observational Study Aimed at Comprehensive Assessment of Psychiatric Inpatients Based on Objective Data and Prescriptions for Reducing Long-Term Hospitalization

Region

Japan


Condition

Condition

schizophrenia

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Clarifying the characteristics of long-term inpatients in Japanese psychiatric hospitals and reducing long-term hospitalization

Basic objectives2

Others

Basic objectives -Others

Regularly investigate sleep variables, clinical psychological test scores, and medication treatment guideline compliance rates in patients with schizophrenia.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

5-Year Discharge Rate

Key secondary outcomes

sleep variables, clinical psychological test scores, and schizophrenia medication treatment guideline compliance rate


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

(1) A diagnosis of schizophrenia (DSM-5)
(2) Hospitalized for more than 1 year consecutively

Key exclusion criteria

(1) Patients with complications of serious physical diseases
(2) Patients whom the principal investigator or attending physician determines to be unsuitable as subjects

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Yusuke
Middle name
Last name Arai

Organization

Kurita hospital

Division name

Department of psychiatry

Zip code

380-0921

Address

695 Kurita, Nagano City, Nagano Prefecture

TEL

026-226-1311

Email

y-arai@shinshu-u.ac.jp


Public contact

Name of contact person

1st name Yusuke
Middle name
Last name Arai

Organization

Kurita hospital

Division name

Department of psychiatry

Zip code

380-0921

Address

695 Kurita, Nagano City, Nagano Prefecture

TEL

026-226-1311

Homepage URL


Email

y-arai@shinshu-u.ac.jp


Sponsor or person

Institute

Kurita hospital

Institute

Department

Personal name



Funding Source

Organization

N/A

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kurita hospital

Address

695 Kurita, Nagano City, Nagano Prefecture

Tel

026-226-1311

Email

y-arai@shinshu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 01 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 12 Month 29 Day

Date of IRB

2023 Year 12 Month 29 Day

Anticipated trial start date

2024 Year 01 Month 01 Day

Last follow-up date

2028 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

As new content for the research purpose, we plan to conduct a one-week actigraphy test and a questionnaire survey every six months. Other data will be obtained from routine clinical data.


Management information

Registered date

2024 Year 01 Month 22 Day

Last modified on

2024 Year 01 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060953


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name